Validation of a Bifunctional Cell Therapy to Improve the Prognosis of Pediatric Brain Tumors Following Radiotherapy

Description

The project focuses on the validation of a bifunctional cell therapy combining mesenchymal stem cells (MSCs) and melatonin to improve outcomes in pediatric brain tumors after radiotherapy. It evaluates how this approach can enhance post-radiotherapy prognosis by targeting tumor progression and radiation-induced damage, aiming to improve therapeutic efficacy and long-term outcomes in childhood brain cancer.

Project investigators

• Vivian Capilla González – Principal Investigator

Funding entities

Instituto de Salud Carlos III